These results demonstrate that the neuroprotective effect of VB is related to the modulation of neuroinflammation via the NF-κB-p65 pathway, making VB a hopeful candidate drug for the prevention and treatment of AD [86]. This evidence concerns the gene NFKB1 and Alzheimer disease.